Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
712 people get THRX articles and Market Currents by email alert.
Get email alerts on THRX »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
-
Marketwire (May 13, 2013)
-
Marketwire (May 10, 2013)
-
Marketwire (Apr 25, 2013)
-
Marketwire (Apr 23, 2013)
-
Marketwire (Apr 22, 2013)
-
-
Marketwire (Apr 18, 2013)
-
Marketwire (Apr 17, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
Theravance: Buy This Biopharma On WeaknessChris Lau • Mon, Aug 13, 2012
-
Theravance: Vote Of Confidence?The Value Investor • Tue, Apr 3, 2012 -
-
-
Theravance May Be Moving HigherM. E. Garza • Wed, Nov 9, 2011 -
Theravance: Fairly Balanced Risk / Reward ProfileZacks Investment Research • Thu, Dec 30, 2010 -
-
Theravance Narrows Its LossesZacks Investment Research • Fri, Apr 24, 2009
-
FDA Sets Date for Theravance Drug ReviewBrett Scott • Fri, Jan 11, 2008
-
-
-
-
-
-
-
-
-
-
-
-
Seth Klarman's Top Stock PicksInsider Monkey • Wed, Feb 20
-
-
-
-
-
-
Tracking Seth Klarman's Baupost Group Holdings - Q3 2012 UpdateJohn Vincent • Wed, Nov 14, 2012
-
-
For NovaBay, Simplicity Is The Father Of InventionRyan's View • Mon, Nov 12, 2012
-
Theravance's CEO Discusses Q3 2012 Results - Earnings Call TranscriptTue, Oct 30, 2012 • 1 Comment
-
Theravance Inc. CEO Discusses Q3 2010 Results - Earnings Call TranscriptThu, Oct 21, 2010
-
Theravance Inc Q2 2010 Earnings Call TranscriptThu, Jul 22, 2010
-
Theravance Inc. Q1 2010 Earnings Call TranscriptWed, Apr 21, 2010
-
Theravance, Inc. Q3 2009 Earnings Call TranscriptTue, Oct 27, 2009
-
Theravance, Inc. Q4 2008 Earnings Call TranscriptThu, Feb 12, 2009
-
Theravance, Inc. Q3 2008 Earnings Call TranscriptWed, Oct 29, 2008
-
Marketwire (May 13, 2013)
-
Marketwire (May 10, 2013)
-
Marketwire (Apr 25, 2013)
-
Marketwire (Apr 23, 2013)
-
Marketwire (Apr 22, 2013)
-
Marketwire (Apr 18, 2013)
-
Marketwire (Apr 17, 2013)
-
Marketwire (Apr 17, 2013)
-
at CNBC.com (Apr 15, 2013)
-
Marketwire (Apr 11, 2013)
-
Marketwire (Feb 21, 2013)
-
Marketwire (Feb 13, 2013)
-
Marketwire (Feb 12, 2013)
-
Marketwire (Jan 31, 2013)
-
Marketwire (Jan 29, 2013)
-
Marketwire (Jan 24, 2013)
THRX vs. ETF Alternatives
Company Description
Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates. We are focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Thursday, April 25, 4:48 PM Theravance (THRX) races 8% higher in late trading. Concurrently with the release of its Q1 report, THRX announces it intends to split into two independent publicly traded companies. One of the companies will remain focused on "biopharmaceutical operations,"while the other will dedicate itself to managing the "late-stage respiratory assets partnered with GlaxoSmithKline." In other words: THRX is creating a separate company to manage Breo Ellipta/Relvar, the COPD inhaled treatment recently recommended for approval in an FDA panel vote. Comment! [Healthcare, Earnings, On the Move]
- Thursday, April 25, 4:24 PM Theravance (THRX): Q1 EPS of -$0.39 misses by $0.01. Revenue of $1.34M misses by $0.92M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Thursday, April 25, 12:10 AM Notable earnings after Thursday’s close: AEM, ALTR, AMCC, AMKR, AMZN, BIDU, BJRI, BLDR, BMRN, CALX, CAMP, CB, CBG, CENX, CERN, CINF, CLWR, CRUS, CSTR, CTCT, DECK, DLB, ELY, EMN, EXPE, FII, FR, FSL, GERN, IGT, IM, INAP, INFA, KBR, KEG, KLAC, LEG, MCRS, MXIM, N, NR, NTGR, OLN, PFG, PKI, PMCS, QLIK, RMD, RRC, RSG, SBUX, SIMO, SPN, SWKS, SYNA, TCO, THRX, TLAB, UHS, VPRT, VRSN, WRE, WYNN Comment! [Earnings]
- Wednesday, April 24, 5:35 PM Notable earnings after Thursday’s close: AEM, ALTR, AMCC, AMKR, AMZN, BIDU, BJRI, BLDR, BMRN, CALX, CAMP, CB, CBG, CENX, CERN, CINF, CLWR, CRUS, CSTR, CTCT, DECK, DLB, ELY, EMN, EXPE, FII, FR, FSL, GERN, IGT, IM, INAP, INFA, KBR, KEG, KLAC, LEG, MCRS, MXIM, N, NR, NTGR, OLN, PFG, PKI, PMCS, QLIK, RMD, RRC, RSG, SBUX, SIMO, SPN, SWKS, SYNA, TCO, THRX, TLAB, UHS, VPRT, VRSN, WRE, WYNN Comment! [Earnings]
- Tuesday, February 12, 4:07 PM Theravance (THRX): Q4 EPS of -$0.33 beats by $0.03. Revenue of $5.79M beats by $1.91M. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Tuesday, February 12, 12:10 AM Notable earnings after Tuesday’s close: ACC, AXLL, BWLD, CLF, CLWR, DDR, FRT, FTI, HTS, LPSN, NRP, NTGR, RAX, RENN, RKUS, SCI, SGEN, SKT, SVM, THRX, TRLA, WU, XNPT 1 Comment [Earnings]
- Monday, February 11, 5:35 PM Notable earnings after Tuesday’s close: ACC, AXLL, BWLD, CLF, CLWR, DDR, FRT, FTI, HTS, LPSN, NRP, NTGR, RAX, RENN, RKUS, SCI, SGEN, SKT, SVM, THRX, TRLA, WU, XNPT 1 Comment [Earnings]
- Tuesday, October 30, 2012, 6:01 PM Theravance (THRX): Q3 EPS of -$0.37 beats by $0.02. Revenue of $1.4M (-77.8% Y/Y) misses by $0.5M. (PR) Comment! [Earnings, Healthcare]
- Tuesday, July 31, 2012, 6:46 PM Theravance (THRX): Q2 EPS of -$0.42 in-line. Revenue of $1.4M (-78.1% Y/Y) misses by $0.57M. (PR) Comment! [Earnings, Healthcare]
- Thursday, April 26, 2012, 4:46 PM Theravance (THRX): Q1 EPS of $0.93 misses by $0.09. Revenue of $127.1M (+1917% Y/Y) beats by $16M. (PR) Comment! [Earnings, Healthcare]
- Thursday, February 9, 2012, 6:11 PM Theravance (THRX): Q4 EPS of -$0.45 misses by $0.06. Revenue of $5.4M (-21.7% Y/Y) misses by $1.3M. (PR) Comment! [Earnings, Healthcare]
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
smokeyRose
on the Filp side I lost a little on $THRX was up now down but i will long this Money maker! - View all 0 replies
-
- View all 0 replies
-
Red Acre Investments
just published part 1 of our April Biotech binary event watch : http://bit.ly/ZmquIg $AGN, $THRX, $ENDP, $SCMP, $GILD - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Skull & Bones
Some kind of BIG news on $THRX looks imminent.......interesting price movement in the shares over the past several days. - View all 0 replies
LATEST REPLIES
-
Scott Matusow
I will be writing about $LGND and others very soon. some other good one out there like $IPXL and $THRX - View all 3 replies
-
-
-
- View all 1 replies
-
